Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 715, doi. 10.1007/s40265-018-0906-6
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 6
Results: 8
1
2
Burosumab: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 707, doi. 10.1007/s40265-018-0905-7
- By:
- Publication type:
- Article
3
Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 675, doi. 10.1007/s40265-018-0902-x
- By:
- Publication type:
- Article
4
Apalutamide: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 699, doi. 10.1007/s40265-018-0900-z
- By:
- Publication type:
- Article
5
Baloxavir: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 693, doi. 10.1007/s40265-018-0899-1
- By:
- Publication type:
- Article
6
Role of Methotrexate in the Management of Psoriatic Arthritis.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 611, doi. 10.1007/s40265-018-0898-2
- By:
- Publication type:
- Article
7
Herbal Dietary Supplements for Erectile Dysfunction: A Systematic Review and Meta-Analysis.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 643, doi. 10.1007/s40265-018-0897-3
- By:
- Publication type:
- Article
8
Individualising Therapy to Minimize Bacterial Multidrug Resistance.
- Published in:
- Drugs, 2018, v. 78, n. 6, p. 621, doi. 10.1007/s40265-018-0891-9
- By:
- Publication type:
- Article